Anti-KIAA0895 monoclonal antibody

Pre-made anti-KIAA0895 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to KIAA0895/KIAA0895 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2557-Ab-1/ GM-Tg-hg-IP2557-Ab-2Anti-Human KIAA0895 monoclonal antibodyHuman
GM-Tg-rg-IP2557-Ab-1/ GM-Tg-rg-IP2557-Ab-2Anti-Rat KIAA0895 monoclonal antibodyRat
GM-Tg-mg-IP2557-Ab-1/ GM-Tg-mg-IP2557-Ab-2Anti-Mouse KIAA0895 monoclonal antibodyMouse
GM-Tg-cynog-IP2557-Ab-1/ GM-Tg-cynog-IP2557-Ab-2Anti-Cynomolgus/ Rhesus macaque KIAA0895 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2557-Ab-1/ GM-Tg-felg-IP2557-Ab-2Anti-Feline KIAA0895 monoclonal antibodyFeline
GM-Tg-cang-IP2557-Ab-1/ GM-Tg-cang-IP2557-Ab-2Anti-Canine KIAA0895 monoclonal antibodyCanine
GM-Tg-bovg-IP2557-Ab-1/ GM-Tg-bovg-IP2557-Ab-2Anti-Bovine KIAA0895 monoclonal antibodyBovine
GM-Tg-equg-IP2557-Ab-1/ GM-Tg-equg-IP2557-Ab-2Anti-Equine KIAA0895 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2557-Ab-1/ GM-Tg-hg-IP2557-Ab-2; GM-Tg-rg-IP2557-Ab-1/ GM-Tg-rg-IP2557-Ab-2;
GM-Tg-mg-IP2557-Ab-1/ GM-Tg-mg-IP2557-Ab-2; GM-Tg-cynog-IP2557-Ab-1/ GM-Tg-cynog-IP2557-Ab-2;
GM-Tg-felg-IP2557-Ab-1/ GM-Tg-felg-IP2557-Ab-2; GM-Tg-cang-IP2557-Ab-1/ GM-Tg-cang-IP2557-Ab-2;
GM-Tg-bovg-IP2557-Ab-1/ GM-Tg-bovg-IP2557-Ab-2; GM-Tg-equg-IP2557-Ab-1/ GM-Tg-equg-IP2557-Ab-2
Products NameAnti-KIAA0895 monoclonal antibody
Formatmab
Target NameKIAA0895
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-KIAA0895 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2557-Ag-1Recombinant multi-species K0895/ KIAA0895 protein
    ORF Viral VectorpGMLPm005091mouse 9530077C05Rik Lentivirus plasmid
    ORF Viral VectorvGMLPm005091mouse 9530077C05Rik Lentivirus particle


    Target information

    Target IDGM-IP2557
    Target NameKIAA0895
    Gene ID23366,68283,315473,706527,482400,101100955,527805,100070555
    Gene Symbol and Synonyms1110003N12Rik,9530077C05Rik,AABR07069466.1,KIAA0895,MATCAP2,mKIAA0895,RGD1561444
    Uniprot AccessionQ8NCT3
    Uniprot Entry NameK0895_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000164542
    Target ClassificationN/A

    The target: KIAA0895, gene name: KIAA0895, also named as . .



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.